Yi Z. Inhibition of integrin receptor by increasing concentrations and treatment durations with Cilengitide increases the sensitivity of killing in vivo of U87 glioma cancer cell xenograft mouse. MS [Internet]. 2024 Feb. 19 [cited 2026 Nov. 4];2(1):382. Available from: https://ms.deanfrancis.press/article/view/1269